News
16h
EXAS Q2 Deep Dive: Portfolio Expansion and Productivity Drive Guidance Increase Amid Market Caution
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced better-than-expected revenue in Q2 CY2025, with sales ...
Zacks Investment Research on MSN13h
EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up
Exact Sciences Corporation EXAS reported earnings per share (EPS) of 22 cents in the second quarter of 2025 compared to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback